David S Grass

Title: The Innovations of David S. Grass

Introduction

David S. Grass is an accomplished inventor based in Lawrenceville, NJ (US). He is known for his significant contributions to the field of biotechnology, particularly in the development of transgenic animals. His work has implications for pharmacological research and the testing of new compounds.

Latest Patents

David S. Grass holds a patent for "Phospholipase A.sub.2 expressing transgenic animals." This invention concerns transgenic animals that express an abnormally high level of phospholipase A.sub.2 in their serum, liver, lung, kidney, and skin. Specifically, it includes rats and mice that express human non-pancreatic, low molecular weight phospholipase A.sub.2. Although these animals are transfected with a normal human gene, they develop various pathological signs and produce the enzyme ectopically. The animals are useful for testing compounds to determine whether they possess in vivo activity as phospholipase inhibitors or antagonists suitable for pharmacological use. David S. Grass has 1 patent to his name.

Career Highlights

David S. Grass is associated with Dnx Biotherapeutics, where he continues to innovate and contribute to the field of biotherapeutics. His work is pivotal in advancing the understanding of phospholipase A.sub.2 and its potential applications in medicine.

Collaborations

David has collaborated with notable colleagues, including C. Frank Bennett and Mark E. Swanson. Their combined expertise enhances the research and development efforts at Dnx Biotherapeutics.

Conclusion

David S. Grass is a prominent figure in the field of biotechnology, with a focus on transgenic animals and their applications in pharmacological research. His innovative work continues to pave the way for advancements in medical science.